Cargando…

A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma

BACKGROUND: The use of statins is a potential protective factor against the development of hepatocellular carcinoma. Therefore, we conducted a meta-analysis to evaluate the contribution of statins to the risk of hepatocellular carcinoma. METHODS: We searched for PubMed and EMBASE through January 202...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yikai, Wang, Wenjun, Wang, Muqi, Shi, Juanjuan, Jia, Xiaoli, Dang, Shuangsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958112/ https://www.ncbi.nlm.nih.gov/pubmed/35356132 http://dx.doi.org/10.1155/2022/5389044

Ejemplares similares

Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
por: Wang, Yikai, et al.
Publicado: (2023)

Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma
por: Zhang, Xin, et al.
Publicado: (2021)

hOGG1 Ser326Cys Polymorphism and Risk of Hepatocellular Carcinoma among East Asians: A Meta-Analysis
por: Wang, Wenjun, et al.
Publicado: (2013)

Using WeChat, a Chinese Social Media App, for Early Detection of the COVID-19 Outbreak in December 2019: Retrospective Study
por: Wang, Wenjun, et al.
Publicado: (2020)

Risk of hepatitis B virus reactivation following treatment with abatacept: A retrospective study of international pharmacovigilance databases
por: Wang, Jingjing, et al.
Publicado: (2022)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Predicting Death Risk in Patients with Severe Hand, Foot and Mouth Disease
por: Li, Yaping, et al.
Publicado: (2020)

Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
por: Islam, Md. Mohaimenul, et al.
Publicado: (2020)

Seasonality of cellulitis: evidence from Google Trends
por: Zhang, Xin, et al.
Publicado: (2018)

Statin Use Reduces the Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis and Systematic Review
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)

Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Statin use and the prognosis of patients with hepatocellular carcinoma: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis
por: Chang, Yue, et al.
Publicado: (2020)

Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus
por: Liu, Jingkun, et al.
Publicado: (2016)

Associations of psychological wellbeing with COVID-19 hospitalization and mortality in adults aged 50 years or older from 25 European countries and Israel
por: Wang, Wenjun, et al.
Publicado: (2023)

Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus
por: Wang, Wenjun, et al.
Publicado: (2016)

MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2
por: Wang, Yuan, et al.
Publicado: (2018)

Statins on hepatocellular carcinoma risk in hepatitis B or C patients protocol for a systematic review and meta-analysis
por: Li, Zhiguo, et al.
Publicado: (2018)

MicroRNA-376c-3p Facilitates Human Hepatocellular Carcinoma Progression via Repressing AT-Rich Interaction Domain 2: Erratum
por: Wang, Yuan, et al.
Publicado: (2022)

Statin use and endometrial cancer risk: a meta-analysis
por: Yang, Jing, et al.
Publicado: (2017)

Statin use and risk of liver cancer: an update meta-analysis
por: Shi, Meng, et al.
Publicado: (2014)

Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
por: Bai, Shuang, et al.
Publicado: (2016)

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
por: Li, Xiaofei, et al.
Publicado: (2020)

Statin use and the risk of ovarian and endometrial cancers: a meta-analysis
por: Wang, Yizi, et al.
Publicado: (2019)

Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
por: Yi, Sang-Wook, et al.
Publicado: (2019)

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
por: Vell, Mara Sophie, et al.
Publicado: (2023)

Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma
por: Shi, Muqi, et al.
Publicado: (2020)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Statins and the Risk of Lung Cancer: A Meta-Analysis
por: Tan, Min, et al.
Publicado: (2013)

Cost-effectiveness of a national enterovirus 71 vaccination program in China
por: Wang, Wenjun, et al.
Publicado: (2017)

Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
por: Wang, Xinhui, et al.
Publicado: (2020)

Statin use and mortality of patients with prostate cancer: a meta-analysis
por: Meng, Yang, et al.
Publicado: (2016)

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
por: Goh, Myung Ji, et al.
Publicado: (2022)

The Association between MTHFR Gene Polymorphisms and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Qin, Xue, et al.
Publicado: (2013)

Efficacy and mechanism of intermittent fasting in metabolic associated fatty liver disease based on ultraperformance liquid chromatography-tandem mass spectrometry
por: Deng, Jiang, et al.
Publicado: (2022)

Meta-analysis of studies using statins as a reducer for primary liver cancer risk
por: Zhong, Guo-Chao, et al.
Publicado: (2016)

Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery
por: Khajeh, Elias, et al.
Publicado: (2022)

Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Cho, Yongin, et al.
Publicado: (2019)

Statins and the Risk of Gastric Cancer: A Systematic Review and Meta-Analysis
por: Su, Chun-Hsien, et al.
Publicado: (2022)

Statins use and risk of dementia: A dose–response meta analysis
por: Zhang, Xiaoyu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_prg8qpi19k2gir786e51en278g